The IFT20 gene helps cells build and maintain cilia, tiny hairlike structures that act like sensors and help move fluids. This gene plays an important role in early growth and in how tissues such as bone, kidney, and eye develop. If the gene does not work properly, cilia may not function as they should, which can lead to a ciliopathy, a group of conditions that may affect body growth, skeletal development, and several organs. Effects vary with the specific variant.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or guiding activities in the body. Some genes carry the information needed to produce proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they take place, and how strongly they are carried out. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medicines. For a deeper look at this topic, you can find more in the LearnHub.
Overview
IFT20Gene function
What if the gene works
The IFT20 gene helps cells build and maintain cilia, small hairlike structures that sense signals and move fluid. This supports normal development and helps organs such as the eyes, kidneys, and airways work as they should.
Risk
What if the gene does not work
More disruptive variants in the IFT20 gene can cause a ciliopathy that often affects bone growth, leading to a narrow chest, short limbs, and sometimes extra fingers or toes. Milder variants may cause earlier or later, and less or more pronounced, features.
Treatment
What does that mean for your treatment
No IFT20-specific treatment or management approach is currently established in clinical guidelines. The IFT20 gene is being studied in cilia related cell pathways and in some cancer settings, but this has not yet changed routine treatment decisions.
Gene function
What if the gene works
Many cells rely on tiny surface structures called cilia to sense their surroundings and organize signals. In these cells, the IFT20 gene helps build and supply cilia by guiding where key parts are sent. Understanding how the IFT20 gene works helps explain how cells keep cilia working from day to day.
The IFT20 gene helps cells build cilia, which are tiny projections on the cell surface. It supports the delivery of parts needed to assemble these small structures.
Inside cells, the IFT20 gene helps move selected proteins from the Golgi apparatus (the cell's packaging center) toward the base of the cilium. This keeps the cilium supplied with parts used in routine cell signaling.
This gene also supports the ongoing renewal of cilia after they are formed. By helping cargo reach the right place, it helps cells use cilia to sense and respond to signals around them.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
IFT20 gene variants can make the IFT20 protein unstable, shortened, or less able to join the cell’s cilia transport machinery, changing cargo movement inside cilia, the tiny hair like structures on cells. In explaining how IFT20 gene variants affect protein function, milder variants may leave some activity, while more severe variants can sharply reduce the protein or keep it from reaching the right place in the cell.
How variants are linked to conditions
Right now, the IFT20 gene does not have a broadly confirmed link to a specific health condition, though research on how IFT20 gene variants are linked to conditions is still developing. If you carry a confirmed variant in the IFT20 gene, your doctor or genetic counselor can interpret it alongside your symptoms, family history, and test results.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not directly affect health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the IFT20 gene. In families with an IFT20-related condition, risk is mainly shaped by the genetic change itself and family inheritance, and a doctor or genetic counselor can help explain personal risk.
Inheritance of IFT20 variants
Variants in the IFT20 gene linked to known IFT20-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one changed copy from each parent, and the parents are often healthy carriers. When both parents carry an IFT20 gene variant, each pregnancy has a 25% chance of the child inheriting both changed copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither changed copy. This is the established IFT20 inheritance pattern for the conditions currently tied to this gene.
What does my IFT20 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific condition for IFT20 that is used routinely in patient care, though this understanding can change as research develops. If you have a specific IFT20 result and want to know what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your family.
Genetic information
Genetic testing
How you find out about variants
Variants in the IFT20 gene are found through genetic testing for IFT20 variants, usually by sequencing DNA from a blood or saliva sample. A lab reads the gene’s code and compares it with a reference sequence to look for changes. Testing may be done as part of a larger panel, exome, or whole genome test.
When should I consider getting a genetic test?
Genetic testing may be worth considering if a baby or child has signs of a rare condition linked to IFT20, often involving a very small rib cage, short limbs, breathing trouble early in life, or kidney or eye problems. It can also help when similar findings run in the family or when a broader genetic test points to IFT20.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medications. It looks at relationships between genes and drugs to help explain why treatments can work differently from one person to another. For many medicines, genes influence how strongly a drug works and how the body processes it. This understanding can support more informed and individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the IFT20 gene
When should I seek medical advice?
There is no broadly confirmed evidence that this gene changes how people respond to medicines, so questions about side effects, treatment choices, or new symptoms are best discussed with your doctor.
History
IFT20 entered the scientific literature in the early 2000s during work on the protein network involved in building and maintaining cilia, the tiny hairlike structures on many cells. It was identified as one of the intraflagellar transport proteins, a group that helped shape a major area of cell biology research. From these first observations, research expanded steadily, and scientists later recognized that IFT20 had an unusual location at the Golgi apparatus, a cell structure that helps package and move proteins. That finding drew interest because it linked cilia research with broader questions about how cells organize traffic inside themselves. Over time, studies of the IFT20 gene became part of the wider story of how cilia related genes contribute to human health and inherited conditions.